Goldman Sachs Group »

Amneal Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.2M 693k 6.06
2023-12-31 $2.0M 337k 6.07
2023-09-30 $4.7M 1.1M 4.22
2023-06-30 $1.9M 618k 3.10
2023-03-31 $835k 600k 1.39
2022-12-31 $1.3M 666k 1.99
2022-06-30 $2.4M 749k 3.18
2022-03-31 $3.3M 784k 4.17
2021-12-31 $4.7M 984k 4.79
2021-09-30 $5.0M 941k 5.34
2021-03-31 $2.8M 417k 6.73
2020-12-31 $3.3M 717k 4.57
2020-09-30 $1.3M 333k 3.88
2020-06-30 $788k 165k 4.77
2019-12-31 $1.6M 340k 4.82
2019-09-30 $1.0M 361k 2.90
2019-06-30 $1.6M 227k 7.17
2019-03-31 $4.8M 339k 14.17
2018-12-31 $5.5M 409k 13.52
2018-09-30 $6.2M 277k 22.19
2018-06-30 $3.4M 205k 16.41